Messanh Douffan
Dados Biográficos
| ID | 10006232 |
|---|---|
| NOME | Messanh Douffan |
| PRENOMES | Messanh |
| SOBRENOME | Douffan |
| ASSINATURA | DOUFFAN M |
| AFILIAÇÕES | Department of STD, AIDS and Viral Hepatitis |
| VERIFICADO | Não |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 1 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2025 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2025 |
| ÍNDICE H | 0 |
Prevalence of primary HIV-1 drug resistance among antiretroviral-naïve individuals in Togo in 2023
Monitoring pre-treatment drug resistance is a priority to assess the emergence of HIV resistance to antiretrovirals, especially in countries where the transition from dolutegravir-based regimens is already effective on a large scale. The aim of this study was to estimate the prevalence of resistance mutations to different classes of antiretrovirals (ARVs) in HIV-1-naïve persons in Togo in 2023. A cross-sectional study was conducted in 30 HIV care…
Sem obras proeminentes nesta página.
Prevalence of primary HIV-1 drug resistance among antiretroviral-naïve individuals in Togo in 2023
Monitoring pre-treatment drug resistance is a priority to assess the emergence of HIV resistance to antiretrovirals, especially in countries where the transition from dolutegravir-based regimens is already effective on a large scale. The aim of this study was to estimate the prevalence of resistance mutations to different classes of antiretrovirals (ARVs) in HIV-1-naïve persons in Togo in 2023. A cross-sectional study was conducted in 30 HIV care…
Biological Research and Disease Studies (1 obras) · Dolutegravir (1 obras) · Drug resistance (1 obras) · Elvitegravir (1 obras) · HIV drug resistance (1 obras) · HIV Research and Treatment (1 obras) · HIV/AIDS drug development and treatment (1 obras) · Integrase (1 obras) · Integrase inhibitor (1 obras) · Interquartile range (1 obras)